SERUM MATRIX METALLOPROTEINASE-9 LEVELS AND CARDIOVASCULAR RISK RATES IN SUBJECTS WITH METABOLIC SYNDROME

Serin S. O., OKUTURLAR Y., GEDİKBAŞI A., Demir E., Utku I., Kocoglu H., ...More

ACTA MEDICA MEDITERRANEA, vol.31, no.6, pp.1271-1276, 2015 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 31 Issue: 6
  • Publication Date: 2015
  • Journal Name: ACTA MEDICA MEDITERRANEA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1271-1276
  • Istanbul University Affiliated: No

Abstract

Introduction: The present study aimed to evaluate and to compare Framingham Risk Score (FRS), a prediction tool for 10 year risk of coronary heart disease, and Matrix Metalloproteinase-9 (MMP-9) levels (an atherosclerotic proinflammatory marker) in patients with metabolic syndrome (MetS).